• Trade
  • Exchange
  • Buy
  • Trade
  • Exchange
  • Buy
Countdown to Ethereum Shanghai Hard Fork
What does that mean?
Total marketcap
Total volume
BTC 44.54%     ETH 17.93%
  • Trade
  • Exchange
  • Buy

Pfizer PFE Stock

40.35 USD {{ price }} 0.849788% {{change_pct}}%
Market Cap
227.75B USD
LOW - HIGH [24H]
40.13 - 40.5 USD
7.54M USD
{{ volume }}
P/E Ratio
Earnings per share
5.36 USD

Pfizer Price Chart

Pfizer PFE Financial and Trading Overview

Pfizer stock price 40.35 USD
Previous Close 40.01 USD
Open 40.17 USD
Bid 40.42 USD x 2200
Ask 40.43 USD x 800
Day's Range 40.13 - 40.5 USD
52 Week Range 39.23 - 56.32 USD
Volume 6.18M USD
Avg. Volume 22.96M USD
Market Cap 228.24B USD
Beta (5Y Monthly) 0.589968
PE Ratio (TTM) 7.544142
EPS (TTM) 5.36 USD
Forward Dividend & Yield 1.64 (4.01%)
Ex-Dividend Date January 26, 2023
1y Target Est 50.97 USD

PFE Valuation Measures

Enterprise Value 241.72B USD
Trailing P/E 7.544142
Forward P/E 10.697514
PEG Ratio (5 yr expected) -1.48
Price/Sales (ttm) 2.2748964
Price/Book (mrq) 2.3738756
Enterprise Value/Revenue 2.409
Enterprise Value/EBITDA 5.491

Trading Information

Pfizer Stock Price History

Beta (5Y Monthly) 0.589968
52-Week Change -23.92%
S&P500 52-Week Change -12.90%
52 Week High 56.32 USD
52 Week Low 39.23 USD
50-Day Moving Average 42.9 USD
200-Day Moving Average 47.16 USD

PFE Share Statistics

Avg. Volume (3 month) 22.96M USD
Avg. Daily Volume (10-Days) 26.5M USD
Shares Outstanding 5.64B
Float 5.61B
Short Ratio 1.69
% Held by Insiders 0.034%
% Held by Institutions 70.75%
Shares Short 38.49M
Short % of Float 0.68%
Short % of Shares Outstanding 0.68%

Dividends & Splits

Trailing Annual Dividend Rate 1.6
Trailing Annual Dividend Yield 3.99%
5 Year Average Dividend Yield 359.00%
Payout Ratio 0.2925
Last Split Factor 1054:1000

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023


Profit Margin 31.26%
Operating Margin (ttm) 38.86%
Gross Margin 66.01%
EBITDA Margin 43.87%

Management Effectiveness

Return on Assets (ttm) 12.87%
Return on Equity (ttm) 36.22%

Income Statement

Revenue (ttm) 100.33B USD
Revenue Per Share (ttm) 17.89 USD
Quarterly Revenue Growth (yoy) 1.89%
Gross Profit (ttm) 66.23B USD
Net Income Avi to Common (ttm) 31.37B USD
Diluted EPS (ttm) 5.36
Quarterly Earnings Growth (yoy) 47.19%

Balance Sheet

Total Cash (mrq) 22.73B USD
Total Cash Per Share (mrq) 4.05 USD
Total Debt (mrq) 39.38B USD
Total Debt/Equity (mrq) 41.05 USD
Current Ratio (mrq) 1.216
Book Value Per Share (mrq) 17.034

Cash Flow Statement

Operating Cash Flow (ttm) 29.27B USD
Levered Free Cash Flow (ttm) 24.96B USD

Profile of Pfizer

Country United States
State NY
City New York
Address 66 Hudson Boulevard East
ZIP 10001-2192
Phone 212 733 2323
Website https://www.pfizer.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 83000

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Q&A For Pfizer Stock

What is a current PFE stock price?

Pfizer PFE stock price today per share is 40.35 USD.

How to purchase Pfizer stock?

You can buy PFE shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Pfizer?

The stock symbol or ticker of Pfizer is PFE.

Which industry does the Pfizer company belong to?

The Pfizer industry is Drug Manufacturers-General.

How many shares does Pfizer have in circulation?

The max supply of Pfizer shares is 5.64B.

What is Pfizer Price to Earnings Ratio (PE Ratio)?

Pfizer PE Ratio is 7.52798460 now.

What was Pfizer earnings per share over the trailing 12 months (TTM)?

Pfizer EPS is 5.36 USD over the trailing 12 months.

Which sector does the Pfizer company belong to?

The Pfizer sector is Healthcare.